Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?

EuroIntervention 2016;12:Y28-Y32. DOI: 10.4244/EIJV12SYA7

Tarun Chakravarty
Tarun Chakravarty, MD; Yigal Abramowitz, MD; Hasan Jilaihawi, MD; Raj R. Makkar*, MD
Cedars-Sinai Heart Institute, Los Angeles, CA, USA

Symptomatic transcatheter heart valve (THV) thrombosis is noted in up to 1% of patients after transcatheter aortic valve replacement. Recently, hypoattenuated leaflet thickening and reduced leaflet motion of bioprosthetic aor

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Interventions for valvular diseaseTAVI
Read next article
Current status of transcatheter valve therapy in Europe: results from an EAPCI survey

Latest news